Jacobson Allan Steven bought PTCT
November 25, 2025 · Form 4 insider transaction
Jacobson Allan Steven bought 7,900 shares of PTC Therapeutics, Inc. at $18.01 per share, a transaction worth $142.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,900
Price
$18.01
Total value
$142.3K
InsiderJacobson Allan Steven
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 25, 2025
Filing dateNovember 26, 2025
Shares owned after25,351
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 12, 2025